Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Minerva Neurosciences (NERV) Current Leases (2019 - 2021)

Minerva Neurosciences filings provide 3 years of Current Leases readings, the most recent being $16288.0 for Q2 2021.

  • On a quarterly basis, Current Leases fell 91.19% to $16288.0 in Q2 2021 year-over-year; TTM through Jun 2021 was $16288.0, a 91.19% decrease, with the full-year FY2020 number at $111229.0, down 35.67% from a year prior.
  • Current Leases hit $16288.0 in Q2 2021 for Minerva Neurosciences, down from $64350.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $184777.0 in Q2 2020 to a low of $16288.0 in Q2 2021.
  • Median Current Leases over the past 3 years was $156956.0 (2020), compared with a mean of $126466.6.
  • Biggest five-year swings in Current Leases: crashed 35.67% in 2020 and later tumbled 91.19% in 2021.
  • Minerva Neurosciences' Current Leases stood at $172901.0 in 2019, then crashed by 35.67% to $111229.0 in 2020, then tumbled by 85.36% to $16288.0 in 2021.
  • The last three reported values for Current Leases were $16288.0 (Q2 2021), $64350.0 (Q1 2021), and $111229.0 (Q4 2020) per Business Quant data.